Switzerland approves use of Roche COVID treatment

Monday, 27. December 2021 12:04

The Swiss Agency for Therapeutic Products announced on Monday it has approved COVID-19 treatment Ronapreve jointly developed by Roche and Regeneron Pharmaceuticals.

However, Swissmedic noted that the treatment's effects against the Omicron coronavirus variant weren't submitted in this procedure.

The recommendation comes after the European Medicines Agency authorized the Regeneron-Roche COVID-19 antibody cocktail as treatment in the European Union last month.

Related Links: Regeneron Pharmaceuticals Inc.Roche Holding
Baha Breaking News (BBN) / ND